Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis. Supplementary data

dataset

posted on 2023-02-28, 07:14 authored by Xueyin Zhou, Jiasheng Cao, Win Topatana, Tianao Xie, Tianen Chen, Jiahao Hu, Shijie Li, Sarun Juengpanich, Ziyi Lu, Bin Zhang, Kaitai Wang, Xu Feng, Jiliang Sheng, Mingyu Chen

PRISMA checklist.